PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1566008
PUBLISHER: Blueweave Consulting | PRODUCT CODE: 1566008
India Emerging Infectious Disease Diagnostics Market, By Technology; By Type of Infections; By Disease Type; By Application; By End User; By Region, Trend Analysis, Competitive Landscape & Forecast, 2019-2030
India Emerging Infectious Disease Diagnostics Market Size to Surpass Value of USD 719 Million by 2030
India Emerging Infectious Disease Diagnostics Market is flourishing due to the escalating prevalence of infectious diseases coupled with the expansion of the private healthcare sector, rapid strides in diagnostic technology, and a growing emphasis on early disease diagnosis.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated India Emerging Infectious Disease Diagnostics Market size by value at USD 368.89 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India Emerging Infectious Disease Diagnostics Market size to expand at a CAGR of 10.13% reaching a value of USD 719.27 million by 2030. The Emerging Infectious Disease Diagnostics Market in India is propelled by the convergence of cutting-edge technologies and the increasing demand for rapid, accurate, and cost-effective diagnostics. The COVID-19 pandemic underscored the criticality of infectious disease diagnostics, accelerating the adoption of advanced techniques like next-generation sequencing. As the market transitions from nascent to growth phases, innovative devices and methods are emerging, offering faster turnaround times and improved sensitivity. These developments reshape the healthcare landscape, enabling more effective patient management, enhanced public health surveillance, and accelerated pathogen research. The growth of India Emerging Infectious Disease Diagnostics Market is a testament to the pivotal role of accurate and timely diagnosis in safeguarding public health and driving medical advancements.
Opportunity - Growth of Telemedicine
The growth of telemedicine presents a significant opportunity for the India Emerging Infectious Disease Diagnostics Market. As India's healthcare system faces challenges such as a shortage of doctors and limited healthcare infrastructure in rural areas, telemedicine has emerged as a critical solution for bridging these gaps. The increasing adoption of Information and Communication Technologies (ICT) in healthcare enables more efficient and widespread access to diagnostic services, particularly for infectious diseases. Telemedicine platforms can facilitate timely diagnosis and treatment, especially in remote regions where access to healthcare is limited. The COVID-19 pandemic has further underscored the importance of telemedicine, drove its adoption and highlighting its potential to enhance the reach and effectiveness of infectious disease diagnostics. With supportive government policies and advancements in technology, the telemedicine sector is poised to play a crucial role in the growth of the India Emerging Infectious Disease Diagnostics Market, offering cost-effective and scalable solutions to address the country's healthcare needs.
West India Leads India Emerging Infectious Disease Diagnostics Market
West India region, centered around major cities like Mumbai and Pune, has emerged as a dominant force in the diagnostics market. Its high population density, coupled with a well-established healthcare infrastructure, creates fertile ground for the growth of diagnostic services. The region's dense population increases the risk of rapid disease transmission, necessitating advanced diagnostic capabilities. West India's extensive network of hospitals, diagnostic centers, and research institutions provides a robust foundation for delivering comprehensive and high-quality diagnostic services. The presence of prestigious research institutions in the region fuels innovation in diagnostic technologies. These institutions collaborate with healthcare providers to develop novel diagnostic solutions, further solidifying West India's market leadership. The synergy between advanced research and a well-developed healthcare infrastructure creates an environment conducive to the growth and development of diagnostic solutions, reinforcing the region's dominant position in India Emerging Infectious Disease Diagnostics Market.
Impact of Escalating Geopolitical Tensions on India Emerging Infectious Disease Diagnostics Market
India Emerging Infectious Disease Diagnostics Market may face significant challenges from intensifying geopolitical tensions across the world. Disrupted supply chains, hampered international collaborations, and the diversion of resources can significantly impede the market's growth. This can lead to shortages of essential diagnostic equipment, reagents, and other materials. Moreover, strained relationships between countries can hinder collaborative research efforts, limiting access to advanced technologies and expertise. The diversion of government resources towards national security and defense can also impact healthcare initiatives, including infectious disease diagnostics. This can result in reduced funding for research, development, and deployment of innovative diagnostic tools. The cumulative effect of these factors could significantly slow the market's growth, hindering India's ability to manage infectious diseases and protect public health effectively.
Competitive Landscape
India Emerging Infectious Disease Diagnostics Market is fragmented, with numerous players serving the market. The key players dominating India Emerging Infectious Disease Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc, DANAHER CORPORATION, DiaSorin SpA, Hoffmann-La Roche Ltd, QIAGEN NV, Thermo Fisher Scientific Inc, and Siemens Healthineers AG. The key marketing strategies adopted by the players are facility expansion, product diversification, alliances, collaborations, partnerships, and acquisitions to expand their customer reach and gain a competitive edge in the overall market.
The report's in-depth analysis provides information about growth potential, upcoming trends, and India Emerging Infectious Disease Diagnostics Market statistics. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in India Emerging Infectious Disease Diagnostics Market along with industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyses the growth drivers, challenges, and competitive dynamics of the market.
Table of Contents
1. Research Framework
- 1.1. Research Objective
- 1.2. Product Overview
- 1.3. Market Segmentation
2. Executive Summary
3. India Emerging Infectious Disease Diagnostics Market Insights
- 3.1. Industry Value Chain Analysis
- 3.2. DROC Analysis
- 3.2.1. Growth Drivers
- 3.2.1.1. Rising prevalence of infectious diseases
- 3.2.1.2. Growing private healthcare sector
- 3.2.1.3. Rapid advancements in diagnostic technologies
- 3.2.1.4. Rising awareness about early diagnosis
- 3.2.2. Restraints
- 3.2.2.1. Limited healthcare infrastructure
- 3.2.2.2. Low healthcare expenditure
- 3.2.2.3. Lack of skilled personnel
- 3.2.3. Opportunities
- 3.2.3.1. Increasing emphasis on preventive healthcare
- 3.2.3.2. Growth of telemedicine
- 3.2.3.3. Creasing government initiatives
- 3.2.4. Challenges
- 3.2.4.1. Presence of counterfeit and substandard diagnostic products
- 3.2.4.2. Data Privacy and Security
- 3.2.4.3. Price Sensitivity among significant portion of the Indian population
- 3.2.1. Growth Drivers
- 3.3. Technological Advancements/Recent Developments
- 3.4. Regulatory Framework
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry
4. India Emerging Infectious Disease Diagnostics Market: Pricing Analysis
5. India Emerging Infectious Disease Diagnostics Market: Marketing Strategies
6. India Emerging Infectious Disease Diagnostics Market Overview
- 6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Million)
- 6.2. Market Share & Forecast
- 6.2.1. By Technology
- 6.2.1.1. Polymerase Chain Reaction (PCR)
- 6.2.1.2. Isothermal Nucleic Acid Amplification Technology (INAAT)
- 6.2.1.3. Next-Generation Sequencing (NGS)
- 6.2.1.4. Immunodiagnostics
- 6.2.1.5. Other Technologies
- 6.2.2. By Type of Infections
- 6.2.2.1. Bacterial
- 6.2.2.2. Viral
- 6.2.2.3. Fungal
- 6.2.2.4. Others
- 6.2.3. By Disease Type
- 6.2.3.1. Respiratory Infections
- 6.2.3.2. Sexually Transmitted Infections (STIs)
- 6.2.3.3. Gastrointestinal Infections
- 6.2.3.4. Others
- 6.2.4. By Application
- 6.2.4.1. Laboratory Testing
- 6.2.4.2. Point-of-Care Testing
- 6.2.5. By End User
- 6.2.5.1. Hospitals and Clinics
- 6.2.5.2. Diagnostic Laboratories
- 6.2.5.3. Others
- 6.2.6. By Region
- 6.2.6.1. North India
- 6.2.6.2. South India
- 6.2.6.3. East India
- 6.2.6.4. West India
- 6.2.1. By Technology
7. North India Emerging Infectious Disease Diagnostics Market Overview
- 7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Million)
- 7.2. Market Share & Forecast
- 7.2.1. By Technology
- 7.2.2. By Type of Infections
- 7.2.3. By Disease Type
- 7.2.4. By Application
- 7.2.5. By End User
8. South India Emerging Infectious Disease Diagnostics Market Overview
- 8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Million)
- 8.2. Market Share & Forecast
- 8.2.1. By Technology
- 8.2.2. By Type of Infections
- 8.2.3. By Disease Type
- 8.2.4. By Application
- 8.2.5. By End User
9. East India Emerging Infectious Disease Diagnostics Market Overview
- 9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Million)
- 9.2. Market Share & Forecast
- 9.2.1. By Technology
- 9.2.2. By Type of Infections
- 9.2.3. By Disease Type
- 9.2.4. By Application
- 9.2.5. By End User
10. West India Emerging Infectious Disease Diagnostics Market Overview
- 10.1. Market Size & Forecast, 2019-2030
- 10.1.1. By Value (USD Million)
- 10.2. Market Share & Forecast
- 10.2.1. By Technology
- 10.2.2. By Type of Infections
- 10.2.3. By Disease Type
- 10.2.4. By Application
- 10.2.5. By End User
11. Competitive Landscape
- 11.1. List of Key Players and Their Offerings
- 11.2. India Emerging Infectious Disease Diagnostics Company Market Share Analysis, 2023
- 11.3. Competitive Benchmarking, By Operating Parameters
- 11.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships)
12. Impact of Escalating Geopolitical Tensions in India Emerging Infectious Disease Diagnostics Market
13. Company Profiles (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)
- 13.1. Abbott Laboratories
- 13.2. Becton, Dickinson and Company
- 13.3. bioMerieux S.A.
- 13.4. Bio-Rad Laboratories, Inc.
- 13.5. DANAHER CORPORATION
- 13.6. DiaSorin S.p.A.
- 13.7. Hoffmann-La Roche Ltd
- 13.8. QIAGEN N.V.
- 13.9. Thermo Fisher Scientific Inc.
- 13.10. Siemens Healthineers AG
- 13.11. Other Prominent Players
14. Key Strategic Recommendations
15. Research Methodology
- 15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
- 15.2. Quantitative Research
- 15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
- 15.4. Breakdown of Primary Research Respondents, By Region
- 15.5. Assumption & Limitation
* Financial information of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable
List of Figures
- Figure 1 India Emerging Infectious Disease Diagnostics Market Segmentation
- Figure 2 India Emerging Infectious Disease Diagnostics Market Value Chain Analysis
- Figure 3 Company Market Share Analysis, 2023
- Figure 4 India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Figure 5 India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Figure 6 India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Figure 7 India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Figure 8 India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Figure 9 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Figure 10 India Emerging Infectious Disease Diagnostics Market Share, By Region, By Value (USD Million), 2019-2030
- Figure 11 North India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Figure 12 North India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Figure 13 North India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Figure 14 North India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Figure 15 North India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Figure 16 North India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Figure 17 South India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Figure 18 South India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Figure 19 South India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Figure 20 South India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Figure 21 South India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Figure 22 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Figure 23 East India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Figure 24 East India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Figure 25 East India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Figure 26 East India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Figure 27 East India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Figure 28 East India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Figure 29 West India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Figure 30 West India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Figure 31 West India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Figure 32 West India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Figure 33 West India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Figure 34 West India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
List of Tables
- Table 1 India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Table 2 India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Table 3 India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Table 4 India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Table 5 India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Table 6 India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Table 7 India Emerging Infectious Disease Diagnostics Market Share, By Region, By Value (USD Million), 2019-2030
- Table 8 North India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Table 9 North India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Table 10 North India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Table 11 North India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Table 12 North India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Table 13 North India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Table 14 South India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Table 15 South India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Table 16 South India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Table 17 South India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Table 18 South India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Table 19 South India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Table 20 East India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Table 21 East India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Table 22 East India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Table 23 East India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Table 24 East India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Table 25 East India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Table 26 West India Emerging Infectious Disease Diagnostics Market Size, By Value (USD Million), 2019-2030
- Table 27 West India Emerging Infectious Disease Diagnostics Market Share, By Technology, By Value (USD Million), 2019-2030
- Table 28 West India Emerging Infectious Disease Diagnostics Market Share, By Type of Infections, By Value (USD Million), 2019-2030
- Table 29 West India Emerging Infectious Disease Diagnostics Market Share, By Disease Type, By Value (USD Million), 2019-2030
- Table 30 West India Emerging Infectious Disease Diagnostics Market Share, By Application, By Value (USD Million), 2019-2030
- Table 31 West India Emerging Infectious Disease Diagnostics Market Share, By End User, By Value (USD Million), 2019-2030
- Table 32 Abbott Laboratories Company Overview
- Table 33 Abbott Laboratories Financial Overview
- Table 34 Becton, Dickinson and Company - Company Overview
- Table 35 Becton, Dickinson and Company Financial Overview
- Table 36 bioMerieux S.A. Company Overview
- Table 37 bioMerieux S.A. Financial Overview
- Table 38 Bio-Rad Laboratories, Inc. Company Overview
- Table 39 Bio-Rad Laboratories, Inc. Financial Overview
- Table 40 DANAHER CORPORATION Company Overview
- Table 41 DANAHER CORPORATION Financial Overview
- Table 42 DiaSorin S.p.A. Company Overview
- Table 43 DiaSorin S.p.A. Financial Overview
- Table 44 Hoffmann-La Roche Ltd Company Overview
- Table 45 Hoffmann-La Roche Ltd Financial Overview
- Table 46 QIAGEN N.V. Company Overview
- Table 47 QIAGEN N.V. Financial Overview
- Table 48 Thermo Fisher Scientific Inc. Company Overview
- Table 49 Thermo Fisher Scientific Inc. Financial Overview
- Table 50 Siemens Healthineers AG Company Overview
- Table 51 Siemens Healthineers AG Financial Overview
